Amanote Research
Register
Sign In
Comparing Surgical Therapy and Hormonal Therapy in Incidence of Cardiovascular Disease Among Prostate Cancer Patients in Korea
Value in Health
- United Kingdom
doi 10.1016/j.jval.2017.08.116
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2017
Authors
M Kang
E Park
J Shim
I Choi
J Park
S Kang
J Yang
Publisher
Elsevier BV
Related search
Real-World Incidence and Burden of Adverse Events Among Non-Metastatic Prostate Cancer Patients Treated With Secondary Hormonal Therapies Following Androgen Deprivation Therapy
Journal of Medical Economics
Health Policy
Cardiovascular Risk During Hormonal Treatment in Patients With Prostate Cancer
Cancer Management and Research
Oncology
Prostate Cancer: Localized: Surgical Therapy III (MP54)
Journal of Urology
Urology
Combination Hormonal Therapy: A Reassessment Within Advanced Prostate Cancer
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
Focal Therapy in Prostate Cancer
Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer
Journal of Oncology Practice
Health Policy
Oncology
Discontinuation of Low-Dose Acetylsalicylic Acid Therapy in UK Primary Care: Incidence and Predictors in Patients With Cardiovascular Disease
Pragmatic and Observational Research
Explaining Hormone-Deprivation Therapy Failure in Prostate Cancer Patients
Expert Review of Endocrinology and Metabolism
Endocrinology
Metabolism
Diabetes
Differential Use of Medical Versus Surgical Androgen Deprivation Therapy for Patients With Metastatic Prostate Cancer
Cancer
Cancer Research
Oncology
